Pune, India, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global immortalized cell line market.
Immortalized cell line Market Latest Highlights
Immortalized cell lines have wide application in the field of healthcare and life science. Increasing adoption of cell line system in cancer therapy, increasing research and development activities and growth in biotechnology sector drive the global immortalized cells’ market. The global immortalized cell line market is expected to grow at a CAGR of 6.67% is anticipated to reach USD 7.56 Billion during forecast period 2024-2032.
Taste the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Immortalized cell line market Research Report –Global Forecast to 2032.”
Global Immortalized Cell Line Market Players
ATCC (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Lonza (Switzerland), General Electric Company (U.K.), Selexis SA (Switzerland), Corning Incorporated (U.S.), WuXi AppTec (China)
ATCC or the American Type Culture Collection is a non-profit organization, which collects, stores, and distributes cell lines for research and development. The products offered by the company include cell lines, microorganisms, and bio-products. It is now the largest general culture collection organization in the world.
Thermo Fishers, headquartered in Massachusetts and incorporated in 2006, is one of the leaders in the healthcare industry involved in serving healthcare globally. The company was developed by the merger of Thermo Electron and Fisher Scientific in the year 2006. The company is involved in serving the science with improved patient diagnostics, life sciences research, solve complex analytical challenges, and increase laboratory productivity. The company provides comprehensive support to its customers across the globe with its various brands: Thermo Scientific, Fisher Scientific, Applied Biosystems, Invitrogen, and Unity Lab Services.
The global immortalized cell lines market is segmented on the basis of methods, which includes virus induction, hTERT expression, inactivation of tumor suppression genes, and other methods. On the basis of technology, the market is segmented into SV40 large T-antigen, MycT58A, p53 cell, and other technologies. On the basis of application, the market is segmented into stem cell therapy, cell transplantation, drug transport, and others.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Immortalized cell line Market Research Report
Regional Analysis
The global immortalized cell lines market consists of four regions: Americas, Europe, Asia Pacific and the Middle East & Africa. America dominates the global market owing to increasing applications of cell lines in cancer therapy, and use of innovative technology for development of cell lines drive the growth of this market in America. Europe is the second leading market in the globe owing to the growing demand for the immortalized cell lines and demand of technological advancement in the field of microbiology and healthcare. Asia Pacific is experiencing steady growth in this market due to increasing number of biotechnology based companies in developing countries. The Middle East & Africa holds less share in the global market of immortalized cell lines